We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Kyle
McGovern
k.mcgovern@imperial.ac.uk
Kyle
McGovern
k.mcgovern@imperial.ac.uk
Prof
Rohini
Sharma
rohini.sharma2@nhs.net
Diseases of liverPersons encountering health services for examination and investigationMalignant neoplasms of digestive organs
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
This is a multi site Open label two arm randomised control trial of 652 participants to describe the efficacy of patient navigators for attendance at HCC (Hepatology Carcinoma) surveillance.
Patients with cirrhosis or chronic liver disease will be eligible for HCC surveillance.
A patient navigator will provide scripted phone calls 1 week prior to the appointment and if non-attendance,a follow up phone call.
The study duration would be 3.5 years.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Interventional type: Active Monitoring;
You can take part if:
You may not be able to take part if:
• Previous or current diagnosis of HCC • Child Pugh C cirrhosis • Frailty (Clinical Frailty Scale >7) • Previous liver transplant
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Kyle
McGovern
k.mcgovern@imperial.ac.uk
Kyle
McGovern
k.mcgovern@imperial.ac.uk
Prof
Rohini
Sharma
rohini.sharma2@nhs.net
The study is sponsored by Imperial College of Science, Technology and Medicine and funded by NHS ENGLAND .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 60530
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
